Active substance
Cefoperazone
- SFDA 2
- US FDA 3
- Safety 1
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| CEFOBID 1GM VIAL I-M & I-V | 1 g | powder for solution for injection · Parenteral use | 1 Vial | SAR 20.50 | NCE · Prescription | PFIZER | Withdrawn by regulatory authority · Not Marketed |
| CEFOBID 2GM VIAL I-M & I-V | 2 g | powder for solution for injection · Parenteral use | 1 Vial | SAR 35.25 | NCE · Prescription | PFIZER | Withdrawn by regulatory authority · Not Marketed |
US FDA United States — FDA approvals (Drugs@FDA)
| Product | Strength | Form · route | Applicant | Status | First approved |
|---|---|---|---|---|---|
| CEFOBID | EQ 1GM BASE/VIAL; EQ 2GM BASE/VIAL; EQ 10GM BASE/VIAL | injectable · injection | PFIZER | Discontinued | 18 Nov 1982 |
| CEFOBID IN PLASTIC CONTAINER | EQ 40MG BASE/ML; EQ 20MG BASE/ML | injectable · injection | PFIZER | Discontinued | 23 Jul 1986 |
| CEFOBID | EQ 1GM BASE/VIAL; EQ 2GM BASE/VIAL | injectable · injection | PFIZER | Discontinued | 31 Mar 1995 |
Safety signals and safety-related labeling changes
- US FDA 3 Mar 2025 CEFOBID — safety-related labeling change
Labeling sections changed: Contraindications; Warnings and Precautions; Adverse Reactions; Use in Specific Populations
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.